pre-seed
Stage
2024
Founded
2
Investors
About
ScandiBio Therapeutics is a biotechnology company focused on the development of treatments for metabolic diseases and mitochondrial dysfunction, utilizing metabolic co-factors and artificial intelligence to analyze omics data for therapeutic strategies.
Explore ScandiBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.